These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7915990)

  • 21. In vivo binding of [125I]NH2-carfentanil to mu opioid receptors in mouse brain.
    Tafani JA; Francés B; Coulais Y; Méjean-Galzi A; Goeldner M; Hirth C; Guiraud R; Zajac JM
    Nucl Med Biol; 1994 Feb; 21(2):231-8. PubMed ID: 9234287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]Sufentanil, a superior ligand for mu-opiate receptors: binding properties and regional distribution in rat brain and spinal cord.
    Leysen JE; Gommeren W; Niemegeers CJ
    Eur J Pharmacol; 1983 Feb; 87(2-3):209-25. PubMed ID: 6132825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose.
    Disney A; Olson KM; Shafer AM; Moore SC; Anand JP; Traynor JR; Husbands SM
    ACS Chem Neurosci; 2022 Nov; 13(21):3108-3117. PubMed ID: 36223082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography.
    Prevett MC; Cunningham VJ; Brooks DJ; Fish DR; Duncan JS
    Epilepsy Res; 1994 Sep; 19(1):71-7. PubMed ID: 7813416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
    Fitzgerald LW; Teitler M
    Synapse; 1993 Jun; 14(2):154-9. PubMed ID: 8392757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging opiate receptors in the human brain with positron emission tomography. Potential applications for drug addiction research.
    Sadzot B; Mayberg HS; Frost JJ
    Acta Psychiatr Belg; 1990; 90(1):9-19. PubMed ID: 1670391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate receptors in brain labelled in vivo with [3H]lofentanil.
    Laduron PM; Poncet J; Janssen PF
    Neuropharmacology; 1985 Jul; 24(7):617-20. PubMed ID: 2862603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers.
    Jones AK; Luthra SK; Maziere B; Pike VW; Loc'h C; Crouzel C; Syrota A; Jones T
    J Neurosci Methods; 1988 Mar; 23(2):121-9. PubMed ID: 2833666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo studies of opiate receptors.
    Frost JJ; Dannals RF; Duelfer T; Burns HD; Ravert HT; Langström B; Balasubramanian V; Wagner HN
    Ann Neurol; 1984; 15 Suppl():S85-92. PubMed ID: 6331283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
    Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
    Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosynthesis of an opiate receptor binding radiotracer: [11C]carfentanil.
    Dannals RF; Ravert HT; Frost JJ; Wilson AA; Burns HD; Wagner HN
    Int J Appl Radiat Isot; 1985 Apr; 36(4):303-6. PubMed ID: 2991142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.
    Newberg AB; Ray R; Scheuermann J; Wintering N; Saffer J; Schmitz A; Freifelder R; Karp J; Lerman C; Divgi C
    Nucl Med Commun; 2009 Apr; 30(4):314-8. PubMed ID: 19242386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low sensitivity of the positron emission tomography ligand [11C]diprenorphine to agonist opiates.
    Hume SP; Lingford-Hughes AR; Nataf V; Hirani E; Ahmad R; Davies AN; Nutt DJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):661-7. PubMed ID: 17488881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of opioid receptors in rat sensory neurons in culture.
    Chen JJ; Dymshitz J; Vasko MR
    Mol Pharmacol; 1997 Apr; 51(4):666-73. PubMed ID: 9106633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent precoupling of kappa- but not mu-opioid receptors with a G protein in the absence of agonist.
    Frances B; Puget A; Moisand C; Meunier JC
    Eur J Pharmacol; 1990 Jul; 189(1):1-9. PubMed ID: 2171960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified detection system for neuroreceptor studies in the human brain.
    Bice AN; Wagner HN; Frost JJ; Natarajan TK; Lee MC; Wong DF; Dannals RF; Ravert HT; Wilson AA; Links JM
    J Nucl Med; 1986 Feb; 27(2):184-91. PubMed ID: 3012020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of occupancy of opiate receptors by naltrexone.
    Lee MC; Wagner HN; Tanada S; Frost JJ; Bice AN; Dannals RF
    J Nucl Med; 1988 Jul; 29(7):1207-11. PubMed ID: 2839637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [11C]Carfentanil Binds Preferentially to μ-Opioid Receptor Subtype 1 Compared to Subtype 2.
    Eriksson O; Antoni G
    Mol Imaging; 2015; 14():476-83. PubMed ID: 26461068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.
    Zubieta JK; Gorelick DA; Stauffer R; Ravert HT; Dannals RF; Frost JJ
    Nat Med; 1996 Nov; 2(11):1225-9. PubMed ID: 8898749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model.
    Perry DC; Mullis KB; Oie S; Sadée W
    Brain Res; 1980 Oct; 199(1):49-61. PubMed ID: 6250676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.